NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients

The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.